tradingkey.logo

Merck & Co Inc

MRK
121.930USD
+2.180+1.82%
Đóng cửa 02/06, 16:00ETBáo giá bị trễ 15 phút
303.28BVốn hóa
16.75P/E TTM

Merck & Co Inc

121.930
+2.180+1.82%

Thêm thông tin về Merck & Co Inc Công ty

Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Thông tin của Merck & Co Inc

Mã chứng khoánMRK
Tên công tyMerck & Co Inc
Ngày IPOFeb 06, 2077
Giám đốc điều hànhDavis (Robert M)
Số lượng nhân viên75000
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhFeb 06
Địa chỉ126 East Lincoln Avenue
Thành phốRAHWAY
Sàn giao dịch chứng khoánNASDAQ OMX NASDAQ Basic NYSE
Quốc giaUnited States of America
Mã bưu điện07065
Điện thoại19087404000
Trang webhttps://www.merck.com/
Mã chứng khoánMRK
Ngày IPOFeb 06, 2077
Giám đốc điều hànhDavis (Robert M)

Lãnh đạo công ty của Merck & Co Inc

Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
-47434.00%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
199.21K
+13880.00%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
100.06K
--
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
75.21K
-20000.00%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
65.00K
+11583.00%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+5703.00%
Ms. Patricia F. Russo
Ms. Patricia F. Russo
Independent Director
Independent Director
13.15K
--
Mr. Thomas Henry (Tom) Glocer, J.D.
Mr. Thomas Henry (Tom) Glocer, J.D.
Lead Independent Director
Lead Independent Director
5.10K
--
Mr. Inge G. Thulin
Mr. Inge G. Thulin
Independent Director
Independent Director
2.93K
--
Ms. Pamela J. Craig
Ms. Pamela J. Craig
Independent Director
Independent Director
1.72K
--
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Robert M. (Rob) Davis
Mr. Robert M. (Rob) Davis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
443.60K
-47434.00%
Mr. Sanat Chattopadhyay
Mr. Sanat Chattopadhyay
Executive Vice President and President - Merck Manufacturing Division
Executive Vice President and President - Merck Manufacturing Division
199.21K
+13880.00%
Dr. Dean Y. Li, M.D., Ph.D.
Dr. Dean Y. Li, M.D., Ph.D.
Executive Vice President, President - Merck Research Laboratories
Executive Vice President, President - Merck Research Laboratories
100.06K
--
Mr. Chirfi Guindo
Mr. Chirfi Guindo
Senior Vice President, Chief Marketing Officer - Human Health
Senior Vice President, Chief Marketing Officer - Human Health
75.21K
-20000.00%
Ms. Jennifer L. Zachary
Ms. Jennifer L. Zachary
Executive Vice President, General Counsel
Executive Vice President, General Counsel
65.00K
+11583.00%
Mr. Joseph Edward Romanelli
Mr. Joseph Edward Romanelli
Senior Vice President, President - MSD International Human Health
Senior Vice President, President - MSD International Human Health
28.61K
+5703.00%

Phân tích doanh thu

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Dữ liệu liên quan chưa được công ty công bố.
Theo Khu vựcUSD
Tên
Doanh thu
Tỷ trọng
United States
10.01B
0.00%
Europe, Middle East and Africa
3.68B
0.00%
Latin America
905.00M
0.00%
Other
798.00M
0.00%
Asia Pacific (Other than China and Japan)
764.00M
0.00%
Khác
-16.16B
100.00%
Theo Doanh nghiệp
Theo Khu vực
Dữ liệu liên quan chưa được công ty công bố.

Thống kê Cổ phần

Thời gian cập nhật: T2, 17 Th11
Thời gian cập nhật: T2, 17 Th11
Cổ đông
Loại Cổ đông
Cổ đông
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
10.20%
BlackRock Institutional Trust Company, N.A.
5.69%
State Street Investment Management (US)
4.76%
Wellington Management Company, LLP
3.03%
Geode Capital Management, L.L.C.
2.41%
Khác
73.91%
Cổ đông
Cổ đông
Tỷ trọng
The Vanguard Group, Inc.
10.20%
BlackRock Institutional Trust Company, N.A.
5.69%
State Street Investment Management (US)
4.76%
Wellington Management Company, LLP
3.03%
Geode Capital Management, L.L.C.
2.41%
Khác
73.91%
Loại Cổ đông
Cổ đông
Tỷ trọng
Investment Advisor
42.26%
Investment Advisor/Hedge Fund
26.83%
Research Firm
3.18%
Pension Fund
2.50%
Bank and Trust
2.13%
Sovereign Wealth Fund
1.55%
Hedge Fund
1.05%
Insurance Company
0.68%
Family Office
0.15%
Khác
19.67%

Cổ phần của tổ chức

Thời gian cập nhật: T5, 1 Th01
Thời gian cập nhật: T5, 1 Th01
Chu kỳ Báo cáo
Số lượng tổ chức
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
2025Q4
5411
1.99B
80.21%
-57.82M
2025Q3
5358
2.02B
81.35%
-45.75M
2025Q2
5398
2.02B
80.82%
-16.42M
2025Q1
5446
2.05B
81.47%
-3.32M
2024Q4
5410
2.04B
80.88%
+11.87M
2024Q3
5200
2.01B
79.47%
-7.96M
2024Q2
5181
2.01B
79.28%
-4.86M
2024Q1
5154
2.00B
78.88%
-6.10M
2023Q4
5065
1.99B
78.60%
+584.81K
2023Q3
4871
1.98B
78.17%
-32.03M
Xem thêm

Hoạt động của Cổ đông

Tên
Cổ phiếu nắm giữ
Tỷ trọng
Thay đổi
Thay đổi %
Ngày
The Vanguard Group, Inc.
250.94M
10.11%
-809.74K
-0.32%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
141.15M
5.69%
-1.64M
-1.15%
Sep 30, 2025
State Street Investment Management (US)
118.18M
4.76%
-313.69K
-0.26%
Sep 30, 2025
Wellington Management Company, LLP
75.28M
3.03%
-1.58M
-2.05%
Sep 30, 2025
Geode Capital Management, L.L.C.
59.80M
2.41%
+846.19K
+1.44%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
53.70M
2.16%
-166.01K
-0.31%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
36.11M
1.45%
+1.13M
+3.23%
Jun 30, 2025
Fidelity Management & Research Company LLC
27.61M
1.11%
-866.46K
-3.04%
Sep 30, 2025
Fisher Investments
24.07M
0.97%
-945.57K
-3.78%
Sep 30, 2025
BlackRock Asset Management Ireland Limited
22.50M
0.91%
-281.91K
-1.24%
Sep 30, 2025
Xem thêm

ETF liên quan

Thời gian cập nhật: T7, 6 Th12
Thời gian cập nhật: T7, 6 Th12
Tên
Tỷ trọng
VanEck Pharmaceutical ETF
16.09%
FT Vest DJIA Dogs 10 Target Income ETF
10.79%
First Trust NASDAQ Pharmaceuticals ETF
7.94%
Invesco Dow Jones Industrial Average Dividend ETF
6.94%
First Trust Morningstar Dividend Leaders Index Fund
5.39%
Coastal Compass 100 ETF
5.13%
Invesco Pharmaceuticals ETF
4.96%
VanEck Morningstar Wide Moat Value ETF
4.73%
Vaneck Durable High Dividend ETF
4.65%
Franklin Income Focus ETF
4.56%
Xem thêm
VanEck Pharmaceutical ETF
Tỷ trọng16.09%
FT Vest DJIA Dogs 10 Target Income ETF
Tỷ trọng10.79%
First Trust NASDAQ Pharmaceuticals ETF
Tỷ trọng7.94%
Invesco Dow Jones Industrial Average Dividend ETF
Tỷ trọng6.94%
First Trust Morningstar Dividend Leaders Index Fund
Tỷ trọng5.39%
Coastal Compass 100 ETF
Tỷ trọng5.13%
Invesco Pharmaceuticals ETF
Tỷ trọng4.96%
VanEck Morningstar Wide Moat Value ETF
Tỷ trọng4.73%
Vaneck Durable High Dividend ETF
Tỷ trọng4.65%
Franklin Income Focus ETF
Tỷ trọng4.56%

Cổ tức

Tổng cộng 28.91B USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.
Ngày
Cổ tức
Ngày ghi sổ
Ngày thanh toán
Ngày không hưởng cổ tức
Nov 18, 2025
MRK.NB Interim Cash Dividend of gross USD 0.85 paid on Jan 08, 2026 going ex on Dec 15, 2025
Dec 15, 2025
Jan 08, 2026
Dec 15, 2025
Jul 22, 2025
MRK.NB Final Cash Dividend of gross USD 0.81 paid on Oct 07, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 07, 2025
Sep 15, 2025
May 27, 2025
MRK.NB Interim Cash Dividend of gross USD 0.81 paid on Jul 08, 2025 going ex on Jun 16, 2025
Jun 16, 2025
Jul 08, 2025
Jun 16, 2025
Jan 28, 2025
MRK.NB Interim Cash Dividend of gross USD 0.81 paid on Apr 07, 2025 going ex on Mar 17, 2025
Mar 17, 2025
Apr 07, 2025
Mar 17, 2025
Nov 19, 2024
MRK.NB Final Cash Dividend of gross USD 0.81 paid on Jan 08, 2025 going ex on Dec 16, 2024
Dec 16, 2024
Jan 08, 2025
Dec 16, 2024
Jul 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Oct 07, 2024 going ex on Sep 16, 2024
Sep 16, 2024
Oct 07, 2024
Sep 16, 2024
May 29, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Jul 08, 2024 going ex on Jun 17, 2024
Jun 17, 2024
Jul 08, 2024
Jun 17, 2024
Jan 23, 2024
MRK.NB Interim Cash Dividend of gross USD 0.77 paid on Apr 05, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 05, 2024
Mar 14, 2024
Nov 28, 2023
MRK.NB Final Cash Dividend of gross USD 0.77 paid on Jan 08, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 08, 2024
Dec 14, 2023
Jul 25, 2023
MRK.NB Interim Cash Dividend of gross USD 0.73 paid on Oct 06, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 06, 2023
Sep 14, 2023
Xem thêm

Chia tách cổ phiếu

Ngày
Ngày không hưởng cổ tức
Loại
Tỷ lệ
Không có dữ liệu
Ngày
Ngày không hưởng cổ tức
Loại
Tỷ lệ
Không có dữ liệu
KeyAI